- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04916561
Detection of Covid-19 in Tissue Samples of Orthopedic Origin
Detection of Covid-19 in Tissue Samples of Orthopedic Origin: a Prospective Cohort Study
Background The presence of the Covid-19 virus has been detected in tissues of various origins: nasopharyngeal swabs, sputum, bronchoalveolar fluid, blood, stool and anal swabs. However, it does not appear that the virus is excreted in the urine. The REACTing group (Research & Action Emerging Infectious Diseases) has demonstrated the presence of the virus in the conjunctiva and pleural fluid. This detection was made possible by carrying out quantitative, real-time RT-PCR and sequencing of the viral genes, which are currently the benchmark for the diagnosis of COVID-19. However, it is not known at this time whether the Covid-19 virus is present in joint fluid or in bone.
However, some viruses have a particular bone tropism (Parvovirus B19, HHV6); others have joint tropism (parvovirus B19, HBV, HCV, rubella, HIV, HTLV-1). The presence in "orthopedic" tissues of the various coronaviruses (MERS, SARS, etc.) has never been evaluated in the past. However, cases of pulmonary contamination by coronavirus after bone marrow transplantation have been reported in the literature. A potential location at these levels could cause problems of different kinds.
Rationale First, and concretely, a possible direct transmission by these tissues. The current English and Spanish national recommendations in orthopedics show a controversy as to the risk of intraoperative contamination during medical procedures generating aerosols, in particular those involving instruments at high speed (saw blade, reamer, drill). This transmission could also be a problem during bone marrow transplants, from the iliac crests, for example.
Second, but hypothetically, Covid-19 could become quiescent at the level of the myelo-hematopoietic niches and reactivate at a distance, which could then explain the current interrogation on "absence of immunity" and cases of early revival in patients considered cured. This hypothesis is all the more likely since, always by analogy with Parvovirus B19 or HHV6, a recent alert on cases of myocarditis in children has been issued in Parisian pediatric hospitals and that treatment with tocilizumab, which blocks the action Interleukin 6 receptors, and initially used for joint manifestations of rheumatoid arthritis, appear promising.
연구 개요
상세 설명
- Objective: The objective is to determine if Covid-19 is present in bone and joint tissue from operative parts, extracted during routine procedures, in patients diagnosed with Covid + before the procedure.
- Methods: Sample form orthopedics procedure that is usually collected will be analysed for the detection of Covid-19
- Hypothesis: The presence of the virus in the blood suggests a variable amount of presence in the bone tissues, and to a lesser extent articular, of the weakness of their poor vascularity.
Nevertheless, if this is confirmed, understanding of the natural history of the disease would be greatly improved.In the absence of a virus, this would end the controversy about the possibility of contamination by accident from exposure to the block and modify the national recommendations for good orthopedic practices.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Paris, 프랑스, 75011
- Université de Paris
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- patients eligible for traumatology or orthopedics procedure.
- > 18 years-old with no upper age limit
- diagnosed Covid+ using RT-PCR during the past one month
Exclusion Criteria:
- Pregnant or lactating women or in age to procreate without contraceptive treatment
- History of mental illness or neurological deficit or adults lacking capacity to consent for themselves
- Prisoners or young offenders
- Persons who might not adequately understand verbal explanations or written information given in French, or who have special communication needs
- Subjects having been or being under an infectious or oncological intercurrent disorder
- Heart failure with risk of exercise angina or comorbidity(ies) significantly affecting patient function
- Any participants who are involved in current research or have recently been involved in any research prior to recruitment.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
positive detection rate
기간: immediately after surgery
|
rate of patients with possible detection of the virus in an orthopedic sample
|
immediately after surgery
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
viremia
기간: immediately after surgery
|
virus detection levels in the blood
|
immediately after surgery
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- CovidOS_2020
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
코로나에 대한 임상 시험
-
National Institutes of Health Clinical Center (CC)완전한
-
Endourage, LLC모병긴 COVID | 긴 Covid19 | 포스트 급성 COVID-19 | 장거리 COVID | 장거리 COVID-19 | COVID-19 후 증후군미국
-
Massachusetts General Hospital모병
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention...완전한
-
Yang I. Pachankis모집하지 않고 적극적으로COVID-19 호흡기 감염 | COVID-19 스트레스 증후군 | COVID-19 백신 부작용 | COVID-19 관련 혈전색전증 | COVID-19 집중 치료 후 증후군 | COVID-19 관련 뇌졸중중국
-
University Health Network, Toronto모병
-
Beth Israel Deaconess Medical Center아직 모집하지 않음긴 COVID | COVID 장거리 | COVID-19의 급성 후유증
-
StemCyte, Inc.모병
RT-PCR에 대한 임상 시험
-
Sher-E-Bangla Medical College모병COVID-19에 영향을 받은 환자에서 COVID-19의 장기적인 영향을 평가하기 위해방글라데시
-
Ambry GeneticsCrozer-Keystone Health System; St. Joseph Hospital of Orange; The Saratoga Hospital완전한
-
Oswaldo Cruz FoundationNational Institute of Allergy and Infectious Diseases (NIAID); Wellcome Trust; Walter Reed... 그리고 다른 협력자들완전한
-
Versailles Hospital모집하지 않고 적극적으로
-
QuantuMDx Group LtdPathAI; Bright Research Center; New Day Diagnostics완전한